YARW

12.9009.35%
SW

Steven W. Ryder

Chief Medical Officer

Dr. Steven W. Ryder, also known as Steve, M.D., F.A.C.P, is Chief Medical Officer of Yarrow Bioscience, Inc since July 27, 2026. Dr. Ryder has been an Independent Director of Reata Pharmaceuticals, Inc. since July 11, 2022. He serves as Director of Levo Therapeutics, Inc. Dr. Ryder is Independent Director of MBX Biosciences, Inc. from February 2024. Previously, Dr. Ryder was the Chief Development Officer at Alexion Pharmaceuticals, Inc. (Nasdaq: Formerly ALXN, acquired by AstraZeneca PLC) from July 2013 to December 2018. He served as President of Astellas Pharma Global Development, Inc. a subsidiary of Astellas Pharma Inc. since 2008. He had been Chief Medical Officer at Rallybio Corporation since January 2019 until March 31, 2026. Mr. Ryder served previously as Senior Vice President and Group Therapeutic Area Development Head at Pfizer Global Research and Development. Previously, Dr. Ryder served as Chief Development Officer at Alexion from July 2013 to December 2018. Dr. Ryder earned an M.D. from the Icahn School of Medicine at Mount Sinai.

Positions